A prognostic score in histological node negative breast cancer

Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of cancer 1990-03, Vol.61 (3), p.436-440
Hauptverfasser: CHEVALLIER, B, MOSSERI, V, DAUCE, J. P, BASTIT, P, JULIEN, J. P, ASSELAIN, B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 440
container_issue 3
container_start_page 436
container_title British journal of cancer
container_volume 61
creator CHEVALLIER, B
MOSSERI, V
DAUCE, J. P
BASTIT, P
JULIEN, J. P
ASSELAIN, B
description Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels greater than 5 fmol mg-1 cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P less than 0.05), tumour size (P less than 0.001), histological grading (SBR) (P less than 0.01), ER (P less than 0.001) and PR (P less than 0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) less than or equal to 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR less than or equal to 5 fmol mg-1 protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P less than 0.0001) groups with good, intermediate and bad prognosis.
doi_str_mv 10.1038/bjc.1990.96
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1971289</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79724587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-6e42c7fa619fe888e4e39f84f06c0f528b67aef9238d2de773f8018147f2d87d3</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMotVZXrsXZ6EamJplHkk2hFF9QcKPrkGZu2pRpUpNpwX9vSkvVVbicj3PCh9A1wUOCC_44W-ohEQIPRX2C-qQqaE44ZaeojzFmORYUn6OLGJfpFJizHurRgnJKaB-Nxtk6-LnzsbM6i9oHyKzLFjZ2vvVzq1WbOd9A5mCuOruFbBZAxS7TymkIl-jMqDbC1eEdoM_np4_Jaz59f3mbjKe5Lgvc5TWUVDOjaiIMcM6hhEIYXhpca2wqymc1U2AELXhDG2CsMBwTTkpmaMNZUwzQaN-73sxW0GhwXVCtXAe7UuFbemXl_8TZhZz7rSSCEcpFKrg_FAT_tYHYyZWNGtpWOfCbKJlgtKw4S-DDHtTBxxjAHEcIljvdMumWO91S1Im--fuvI3vwm_K7Q65iUmlCsmbjb6WoGOOiStztnnOq2wQ4AmlrN5WWfgC2tpOv</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79724587</pqid></control><display><type>article</type><title>A prognostic score in histological node negative breast cancer</title><source>MEDLINE</source><source>Nature</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>CHEVALLIER, B ; MOSSERI, V ; DAUCE, J. P ; BASTIT, P ; JULIEN, J. P ; ASSELAIN, B</creator><creatorcontrib>CHEVALLIER, B ; MOSSERI, V ; DAUCE, J. P ; BASTIT, P ; JULIEN, J. P ; ASSELAIN, B</creatorcontrib><description>Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels greater than 5 fmol mg-1 cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P less than 0.05), tumour size (P less than 0.001), histological grading (SBR) (P less than 0.01), ER (P less than 0.001) and PR (P less than 0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) less than or equal to 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR less than or equal to 5 fmol mg-1 protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P less than 0.0001) groups with good, intermediate and bad prognosis.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.1990.96</identifier><identifier>PMID: 2328212</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Lymphatic Metastasis ; Mammary gland diseases ; Medical sciences ; Middle Aged ; Neoplasm Recurrence, Local - diagnosis ; Prognosis ; Retrospective Studies ; Tumors</subject><ispartof>British journal of cancer, 1990-03, Vol.61 (3), p.436-440</ispartof><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-6e42c7fa619fe888e4e39f84f06c0f528b67aef9238d2de773f8018147f2d87d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971289/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971289/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,2728,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19577895$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2328212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHEVALLIER, B</creatorcontrib><creatorcontrib>MOSSERI, V</creatorcontrib><creatorcontrib>DAUCE, J. P</creatorcontrib><creatorcontrib>BASTIT, P</creatorcontrib><creatorcontrib>JULIEN, J. P</creatorcontrib><creatorcontrib>ASSELAIN, B</creatorcontrib><title>A prognostic score in histological node negative breast cancer</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><description>Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels greater than 5 fmol mg-1 cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P less than 0.05), tumour size (P less than 0.001), histological grading (SBR) (P less than 0.01), ER (P less than 0.001) and PR (P less than 0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) less than or equal to 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR less than or equal to 5 fmol mg-1 protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P less than 0.0001) groups with good, intermediate and bad prognosis.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Lymphatic Metastasis</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - diagnosis</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkEtLAzEUhYMotVZXrsXZ6EamJplHkk2hFF9QcKPrkGZu2pRpUpNpwX9vSkvVVbicj3PCh9A1wUOCC_44W-ohEQIPRX2C-qQqaE44ZaeojzFmORYUn6OLGJfpFJizHurRgnJKaB-Nxtk6-LnzsbM6i9oHyKzLFjZ2vvVzq1WbOd9A5mCuOruFbBZAxS7TymkIl-jMqDbC1eEdoM_np4_Jaz59f3mbjKe5Lgvc5TWUVDOjaiIMcM6hhEIYXhpca2wqymc1U2AELXhDG2CsMBwTTkpmaMNZUwzQaN-73sxW0GhwXVCtXAe7UuFbemXl_8TZhZz7rSSCEcpFKrg_FAT_tYHYyZWNGtpWOfCbKJlgtKw4S-DDHtTBxxjAHEcIljvdMumWO91S1Im--fuvI3vwm_K7Q65iUmlCsmbjb6WoGOOiStztnnOq2wQ4AmlrN5WWfgC2tpOv</recordid><startdate>19900301</startdate><enddate>19900301</enddate><creator>CHEVALLIER, B</creator><creator>MOSSERI, V</creator><creator>DAUCE, J. P</creator><creator>BASTIT, P</creator><creator>JULIEN, J. P</creator><creator>ASSELAIN, B</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19900301</creationdate><title>A prognostic score in histological node negative breast cancer</title><author>CHEVALLIER, B ; MOSSERI, V ; DAUCE, J. P ; BASTIT, P ; JULIEN, J. P ; ASSELAIN, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-6e42c7fa619fe888e4e39f84f06c0f528b67aef9238d2de773f8018147f2d87d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Lymphatic Metastasis</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - diagnosis</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHEVALLIER, B</creatorcontrib><creatorcontrib>MOSSERI, V</creatorcontrib><creatorcontrib>DAUCE, J. P</creatorcontrib><creatorcontrib>BASTIT, P</creatorcontrib><creatorcontrib>JULIEN, J. P</creatorcontrib><creatorcontrib>ASSELAIN, B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHEVALLIER, B</au><au>MOSSERI, V</au><au>DAUCE, J. P</au><au>BASTIT, P</au><au>JULIEN, J. P</au><au>ASSELAIN, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A prognostic score in histological node negative breast cancer</atitle><jtitle>British journal of cancer</jtitle><addtitle>Br J Cancer</addtitle><date>1990-03-01</date><risdate>1990</risdate><volume>61</volume><issue>3</issue><spage>436</spage><epage>440</epage><pages>436-440</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels greater than 5 fmol mg-1 cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P less than 0.05), tumour size (P less than 0.001), histological grading (SBR) (P less than 0.01), ER (P less than 0.001) and PR (P less than 0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) less than or equal to 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR less than or equal to 5 fmol mg-1 protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P less than 0.0001) groups with good, intermediate and bad prognosis.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>2328212</pmid><doi>10.1038/bjc.1990.96</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 1990-03, Vol.61 (3), p.436-440
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1971289
source MEDLINE; Nature; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Female
Gynecology. Andrology. Obstetrics
Humans
Lymphatic Metastasis
Mammary gland diseases
Medical sciences
Middle Aged
Neoplasm Recurrence, Local - diagnosis
Prognosis
Retrospective Studies
Tumors
title A prognostic score in histological node negative breast cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T02%3A52%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20prognostic%20score%20in%20histological%20node%20negative%20breast%20cancer&rft.jtitle=British%20journal%20of%20cancer&rft.au=CHEVALLIER,%20B&rft.date=1990-03-01&rft.volume=61&rft.issue=3&rft.spage=436&rft.epage=440&rft.pages=436-440&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/bjc.1990.96&rft_dat=%3Cproquest_pubme%3E79724587%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79724587&rft_id=info:pmid/2328212&rfr_iscdi=true